-
2026-11-06
GenSci R&D Day 2026: Pioneering Innovation From China to the WorldLearn More
-
2026-10-28
IND Approval: GenSci136 Advances into Sj?gren's SyndromeLearn More
-
2026-10-22
Phase 3 trial in China successfully confirms ACARIZAX? safety and efficacy in patients with house dust mite allergyLearn More
-
2026-10-10
GenSci's Oncology Innovation: NDA Approval Secured for Prostate CancerLearn More
-
2025-02-10
Clinical Trial Commencement of GenSci120 Injection ApprovedLearn More
-
2025-01-22
GenSci Showcases the Latest R&D Achievements at J.P. MorganLearn More
-
2025-01-17
NMPA Approves the PD-1 agonist GenSci120 for Clinical Trials CommencementLearn More
-
2024-12-12
GenSci Invites You to Meet Us at Arab Health 2025Learn More
-
2024-11-20
Chinese Monoclonal Anti-IL-1β Breakthrough: Acute Gout Arthritis Treatment Impresses at ACR 2024Learn More
-
2024-11-11
World ADC San Diego 2024: GenSci showcases two innovative pipeline programsLearn More